GPX1 and pancreatic neoplasm: It is currently known that the GPX1 expression level in tumor tissues is negatively correlated with the overall survival time of patients with breast, gastric, and glioma cancers and leukemia but is correlated with a favorable prognosis in pancreatic cancer patients (Table 2).